Jonathan Paul Liebling1,2, Nicholas James Clarkson3, Blair William Gibbs1, Andrew Stephen Yates1, Saoirse Elizabeth O'Sullivan1,4. 1. Centre for Medicinal Cannabis, London, United Kingdom. 2. Cannabis Patient Advocacy & Support Services, London, United Kingdom. 3. PhytoVista Laboratories Ltd., Frome, United Kingdom. 4. Division of Medical Sciences & Graduate Entry Medicine, School of Medicine, Royal Derby Hospital Centre, University of Nottingham, Nottingham, United Kingdom.
Abstract
Introduction: Over-the-counter cannabidiol (CBD) products have seen unprecedented recent growth in the United Kingdom. However, analysis of these predominantly unregulated products from other countries tells us that they are often mislabeled or contain unlabeled and potentially dangerous chemicals. Thus, the aim of the present study was to analyze CBD oils available in the United Kingdom. Materials and Methods: Phytocannabinoids, residual solvent, and heavy metals were measured blinded in 29 widely available CBD products by an independent testing facility using high-performance liquid chromatography with diode-array detection for cannabinoids, Headspace-gas chromatography-flame ionization detector and gas chromatography-mass spectrometry for residual solvents, and inductively coupled plasma-mass spectrometry for heavy metals. Results: The mean advertised CBD content was 4.5%, and the actual mean measured CBD content of products was 3.2% (p=0.053, Mann-Whitney test). Only 11/29 (38%) products were within 10% of the advertised CBD content. Fifty five percent of products had measurable levels of the controlled substances Δ9-tetrahydrocannabinol (mean content 0.04%) or cannabinol (mean content 0.01%), as well as most other phytocannabinoid compounds including cannabidiolic acid (CBDA), cannabidivarin (CBDV), and cannabidivarin acid (CBDVA). Detectable levels of N-pentane, ethanol, isopropanol, heptane, lead, and arsenic were found in many of the CBD products, but these were within acceptable levels. Conclusions: As demonstrated in other countries, the quality of over-the-counter CBD products in the United Kingdom can be substandard, particularly with regard to CBD content, and often contains levels of controlled substances. We recommend that these products be more strictly regulated for consumer welfare.
Introduction: Over-the-counter cannabidiol (CBD) products have seen unprecedented recent growth in the United Kingdom. However, analysis of these predominantly unregulated products from other countries tells us that they are often mislabeled or contain unlabeled and potentially dangerous chemicals. Thus, the aim of the present study was to analyze CBD oils available in the United Kingdom. Materials and Methods: Phytocannabinoids, residual solvent, and heavy metals were measured blinded in 29 widely available CBD products by an independent testing facility using high-performance liquid chromatography with diode-array detection for cannabinoids, Headspace-gas chromatography-flame ionization detector and gas chromatography-mass spectrometry for residual solvents, and inductively coupled plasma-mass spectrometry for heavy metals. Results: The mean advertised CBD content was 4.5%, and the actual mean measured CBD content of products was 3.2% (p=0.053, Mann-Whitney test). Only 11/29 (38%) products were within 10% of the advertised CBD content. Fifty five percent of products had measurable levels of the controlled substances Δ9-tetrahydrocannabinol (mean content 0.04%) or cannabinol (mean content 0.01%), as well as most other phytocannabinoid compounds including cannabidiolic acid (CBDA), cannabidivarin (CBDV), and cannabidivarin acid (CBDVA). Detectable levels of N-pentane, ethanol, isopropanol, heptane, lead, and arsenic were found in many of the CBD products, but these were within acceptable levels. Conclusions: As demonstrated in other countries, the quality of over-the-counter CBD products in the United Kingdom can be substandard, particularly with regard to CBD content, and often contains levels of controlled substances. We recommend that these products be more strictly regulated for consumer welfare.
Entities:
Keywords:
cannabidiol; over the counter; phytocannabinoid; quality
Authors: Marilyn A Huestis; Renata Solimini; Simona Pichini; Roberta Pacifici; Jeremy Carlier; Francesco Paolo Busardò Journal: Curr Neuropharmacol Date: 2019 Impact factor: 7.363
Authors: Marcel O Bonn-Miller; Mallory J E Loflin; Brian F Thomas; Jahan P Marcu; Travis Hyke; Ryan Vandrey Journal: JAMA Date: 2017-11-07 Impact factor: 56.272
Authors: Carmen Rodríguez-Cueto; Irene Santos-García; Laura García-Toscano; Francisco Espejo-Porras; MLuz Bellido; Javier Fernández-Ruiz; Eduardo Muñoz; Eva de Lago Journal: Biochem Pharmacol Date: 2018-08-01 Impact factor: 5.858
Authors: Geoffrey A Dubrow; Rahul S Pawar; Cynthia Srigley; Jennifer Fong Sam; Christian Talavera; Christine H Parker; Gregory O Noonan Journal: J Food Compost Anal Date: 2021-04-01 Impact factor: 4.520
Authors: MaryBeth Dobbins; Mannat Rakkar; Katharine Cunnane; Sarah D Pennypacker; Kimberly G Wagoner; Beth A Reboussin; E Alfonso Romero-Sandoval Journal: Front Public Health Date: 2022-06-17
Authors: Si Huang; Ruiying Qiu; Zhengfa Fang; Ke Min; Teris A van Beek; Ming Ma; Bo Chen; Han Zuilhof; Gert Ij Salentijn Journal: Anal Chem Date: 2022-09-30 Impact factor: 8.008